Live Breaking News & Updates on Global clinical affairs
Stay updated with breaking news from Global clinical affairs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Viz.ai will be announced new clinical data supporting advancements in cardiology care during the American College of Cardiology Scientific Sessions, ACC.24, being held April 6-8 in Atlanta, GA.
Real-world Evidence at the American College of Cardiology Scientific Session 2024 Demonstrates Positive Impact of Viz.ai on Suspected Disease Detection and Patient Triage for Improved Care dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.
Viz.ai Announces Six Clinical Studies that Further Validate Impact of Viz™ Neuro Suite on Patient Care streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ -- ShiraTronics, Inc., a pioneering clinical-stage medical device company, today proudly announced the successful conclusion of enrollment in...
ShiraTronics Completes Australian Pilot Study Enrollment; Prepares for Pivotal Clinical Study philippinetimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from philippinetimes.com Daily Mail and Mail on Sunday newspapers.
ShiraTronics Completes Australian Pilot Study Enrollment; Prepares for Pivotal Clinical Study singaporestar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from singaporestar.com Daily Mail and Mail on Sunday newspapers.
MINNEAPOLIS, Feb. 7, 2024 /PRNewswire/ -- ShiraTronics, Inc., a pioneering clinical-stage medical device company, today proudly announced the successful conclusion of enrollment in their pilot study conducted in Australia for their minimally invasive, implantable migraine therapy. Migraine, recognized globally as a significant cause of disability, particularly among pre-menopausal women, poses a substantial health challenge. For around 2% of...